CAV1 and myopericytoma: In conclusion, the current study suggests that in Egyptian mPC patients, Gleason score, baseline ALP might be combined with periodic assessment of PSA, CAV1 and SLDLRP1 levels; to predict patients’ prognosis and overall survival.